Kranus Health

Overview
Kranus Health is a Munich-headquartered German digital-health company founded in 2020 that develops and commercialises prescription digital therapeutics (DTx) for urology and men's-health indications, most notably erectile dysfunction. Its flagship product Kranus Edera is a fully certified DiGA (Digitale Gesundheitsanwendung / digital health application) approved for reimbursement by the German statutory health insurance system, which allows it to be prescribed by physicians in Germany. Kranus Health has publicly reported that it grew by more than 100 percent in 2021 and positions itself as one of the leading DiGA companies in the German digital prescription-app market. This record has been reclassified from a POOL LABEL Person candidate to a Company record; Kranus Health is an incorporated digital health company, not an individual.

Why this entity matters
Kranus Health matters as a reference entity in the DACH digital-health narrative for four reasons. First, Kranus Health is one of the most-cited German DiGA companies and its flagship Kranus Edera is a canonical example of a fully reimbursable digital prescription therapy under the German DiGA regime. Second, Kranus Health focuses on urology and men's-health indications, an underserved category in digital therapeutics where the intersection of clinical evidence, prescription reimbursement and B2C-scale distribution is unusually challenging. Third, Kranus Health is a canonical reference point for the DACH DiGA-commercialisation narrative and for the broader European debate about whether reimbursable digital therapeutics can build sustainable business models around prescription pathways. Fourth, Kranus Health is a T1 reference entity for Startuprad.io's coverage of German digital health, the DiGA regime, and DACH-founder-driven regulated-market commercialisation.

Company history and product
Kranus Health was founded in 2020 in Munich with a focus on building clinically evidenced, prescription digital therapeutics for urology and men's health, and it chose the German DiGA reimbursement pathway as its core commercial channel. The company's founding cohort combines commercial-operator, product and clinical expertise; the precise names of every founder should be verified against Kranus Health's own site and Crunchbase before publication. Kranus Health's flagship product Kranus Edera is a certified DiGA for erectile dysfunction that is prescribable by physicians in Germany and reimbursable by statutory health insurance. In its Startuprad.io interview Kranus Health publicly reported that the company grew by more than 100 percent in 2021 and positioned Kranus Edera as one of the most successful German digital prescription apps in its category. Publicly reported investors include German venture-capital firms active in digital-health and consumer-health categories; the precise investor line-up and round history should be verified against Crunchbase, Dealroom and Kranus Health's own communications at the point of use. Under the DiGA regime, Kranus Health's business model rests on obtaining and maintaining BfArM listing for its therapies, negotiating reimbursement prices with the German statutory-insurance system and building physician-prescription and adherence infrastructure at scale.

Role in the DACH startup and technology ecosystem
Kranus Health sits at the intersection of three structural themes in the DACH digital-health ecosystem. First, Germany's DiGA regime (established under the Digitale-Versorgung-Gesetz / DVG in 2019) created a new global reference model for prescription digital therapeutics: certified apps can be prescribed by physicians and reimbursed by statutory health insurance, which turns a consumer-app category into a regulated medical-device category with a defined pricing pathway. Kranus Health is one of the most-cited German companies operating under that DiGA regime, and its Kranus Edera is a canonical DiGA case study for the urology / men's health category. Second, DACH digital-health has become one of the most-cited European life-sciences and health-technology categories over the last five years, and Kranus Health is one of the operator-led German DTx companies within that cohort. Third, the DACH DTx cohort faces a shared commercialisation challenge (physician adoption, adherence and reimbursement negotiation) which makes Kranus Health a reference case for the broader question of whether the DiGA regime can produce durable European digital-health companies at scale. Kranus Health connects into Startuprad.io's coverage of German digital health, health-tech founder interviews and DACH regulated-market commercialisation.

Selected relationships and affiliations
Founding and leadership: Kranus Health's founding cohort combines commercial-operator, product and clinical expertise; the precise names of every co-founder and current leadership should be verified against Kranus Health's own site and Crunchbase before publication. Regulatory reference: German Federal Institute for Drugs and Medical Devices (BfArM) as the DiGA-listing authority, and the German statutory health insurance system as the reimbursement counterparty. Flagship product: Kranus Edera (certified DiGA for erectile dysfunction). Publicly reported investors: German venture-capital firms active in digital-health and consumer-health categories (verify precise cap table against Crunchbase / Dealroom and Kranus Health's own communications). Related DACH digital-health cohort: other prominent DiGA companies including HelloBetter, Selfapy and Sonormed / Kalmeda (referenced only as cohort context, not as direct partners). Related Startuprad.io coverage cluster: DACH digital-health founder interviews and DiGA regime coverage.

Startuprad.io relevance
Kranus Health is a T1 reference entity for Startuprad.io's DACH digital-health and DiGA coverage. Startuprad.io has published a stand-alone founder interview positioned as the English-language world premiere for Kranus Health. Kranus Health appears in the following Startuprad.io interview and analysis piece.

An English World Premiere: Meet Kranus Health the Startup Behind Germany's Most Successful Digital Prescription App
Published: 15 March 2026
Last updated: 20 September 2026
Coverage type: Interview
https://www.startuprad.io/post/an-english-world-premiere-meet-kranus-health-the-startup-behind-germany-s-most-successful-digita

Public source context
This profile draws on Kranus Health's own corporate website https://www.kranushealth.com , the Kranus Health LinkedIn company page https://www.linkedin.com/company/kranus-health/ , the Crunchbase organisation profile https://www.crunchbase.com/organization/kranus-health , the BfArM DiGA directory at https://diga.bfarm.de/de/verzeichnis (for verification of Kranus Edera's DiGA listing status), and Startuprad.io's own founder-interview coverage summarised in the coverage item above. Growth figures reported by Kranus Health are self-reported and should be treated as management-disclosed at the point of use.

About this record. This is the public Level 1 layer of Startuprad.io's entity intelligence architecture. Startuprad.io's deeper entity intelligence may include extended profiles, verified relationships, source trails, historical development, monitoring, news signals, custom entity sets, and analytical relationship mapping. These deeper layers are available through Startuprad.io's research, intelligence, and enterprise services.

Need deeper entity intelligence? Startuprad.io provides extended profiles, monitored entity sets, relationship analysis, source-backed research, and custom intelligence services for companies, investors, and institutions. → https://www.startuprad.io/become-a-partner

Members treat Kranus Health as a live signal — the Vault carries our members-only analysis goes deeper into cap-table dynamics, founder implications and operator playbooks that don't fit a public record.
▶ YouTube Membership: https://www.youtube.com/startupradio/join
✉️ Substack: https://startupradio.substack.com/subscribe

About Startuprad.io
Startuprad.io is a European B2B media, data and intelligence platform. It provides structured entity and ecosystem data, source-backed research, datasets and AI/training-data solutions, as well as strategic visibility and access to a professional European audience of founders, investors, executives and B2B decision-makers.

Organizations use Startuprad.io for intelligence and research, structured data and AI applications, executive and company positioning, and trusted B2B reach across Europe.

Canonical record: https://www.startuprad.io/entities/kranus-health